MeDiNova has a large, world-wide patient population reach with sites based around the globe in the UK, South Africa, Spain and the USA.
There are currently 8 sites within the UK, 31 sites across South Africa, 3 sites in Spain and 33 sites located across the USA.
MeDiNova has a significant number of patients who participate in our clinical trials. We use an innovative range of approaches to recruit patients including:
- Direct recruitment through social media, radio, magazine and newspaper advertising.
- GPs, Physicians and Consultants within Healthcare organisations
- Patient organisations
GPs also appreciate this collaborative approach. We frequently
undertake Disease Awareness sessions that are well attended by patients and GPs who find them very informative.
MeDiNova has been very successful in recruiting and retaining patients for clinical trials across a broad spectrum of therapeutic areas.